[Immunomodulating activity of thymogen in acute pancreatitis].
Saĭdakhmedova. Z T ZT
Key Findings
- Acute pancreatitis patients showed reduced T‑cell immunity compared to healthy controls
- Thymogen at 0.5‑0.8 mg improved T‑cell numbers and overall immune markers
- Patients receiving thymogen experienced faster clinical improvement
Practical Outcomes
- Thymogen may aid immune recovery in severe inflammatory conditions like acute pancreatitis, but the data are limited to sick patients and a small sample. It isn’t a proven or recommended supplement for healthy individuals seeking longevity or performance gains, and more rigorous studies are needed before incorporating it into routine protocols.
Summary
In a small study of people with acute pancreatitis, giving the peptide thymogen (0.5‑0.8 mg) as part of their treatment helped restore T‑cell immune function and was linked to better clinical outcomes.
Abstract
Immunity system parameters were explored at 48 persons with diagnosis of acute pancreatitis (AP) and at 36 practically healthy persons (donors). At AP diseased were found declinations in immunity system especially at the side of immunity T-cell link. Including of tymogen in complex treatment at the dose 0.5-0.8 mg for the treatment course at AP diseased was having immune correcting action and leadind to positive dynamics of clinical changes. It was observed elimination of T-cell immune deficiency at AP diseased.
Study Information
pubmed
2000